3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Pancreatic Neoplasms
3
Neoplasms
2
Disease
2
Rectal Neoplasms
1
Pleural Effusion
1
Pleural Diseases
1
Pancreatitis, Chronic
1
Pancreatic carcinoma, familial
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mesothelioma
1
Hereditary pancreatitis
1
Hematologic Diseases
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cardiotoxicity
1
Carcinoma, Hepatocellular
1
Bone Marrow Diseases
1
Interventions
fludarabine
12
Cyclophosphamide
11
Busulfan
8
Mycophenolic Acid
6
Dexamethasone
6
fludarabine phosphate
5
Whole-Body Irradiation
5
Tacrolimus
5
Melphalan
5
Lenalidomide
5
Granulocyte Colony-Stimulating Factor
4
isatuximab
3
Thiotepa
3
Sirolimus
3
Rituximab
3
Methotrexate
3
Cyclosporine
3
Blood Specimen Collection
3
Alemtuzumab
3
pomalidomide
2
pembrolizumab
2
daratumumab
2
Vorinostat
2
Stem Cell Transplantation
2
Platelet Transfusion
2
Ondansetron
2
Interviews as Topic
2
Filgrastim
2
Exercise
2
Etoposide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hematologic Diseases
×
Clinical Laboratory Techniques
×
Clear all
NCT07387354
2026-03-16
MDS
Thomas Jefferson University
Phase 1/2
Not yet recruiting
25 enrolled